|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
TCTR |
|
Last refreshed on:
|
1 April 2024 |
|
Main ID: |
TCTR20141219001 |
|
Date of registration:
|
19/12/2014 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
comparison magnesium sulfate maintenance infusion effect between 2 gram per hour and 1 gram per hour in maternal excessive weight with preeclampsia
|
|
Scientific title:
|
magnesium sulfate maintenance infusion effect between 2 gram per hour and 1 gram per hour in maternal excessive weight with preeclampisa: A Double-blinded Randomized Controlled Trial. |
|
Date of first enrolment:
|
15/01/2015 |
|
Target sample size:
|
40 |
|
Recruitment status: |
Recruiting |
|
URL:
|
https://www.thaiclinicaltrials.org/show/TCTR20141219001 |
|
Study type:
|
Interventional |
|
Study design:
|
Randomized
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
thailand
| | | | | | | |
|
Contacts
|
|
Name:
|
Siraya
kitiyodom |
|
Address:
|
Maharat NaKhon Ratchasima hospital
30000
Nakhonratchasima
Thailand |
|
Telephone:
|
044235042 |
|
Email:
|
gratikpooh@hotmail.com |
|
Affiliation:
|
- |
|
|
Name:
|
Siraya
kitiyodom |
|
Address:
|
Maharat NaKhon Ratchasima hospital
30000
Nakhonratchasima
thailand |
|
Telephone:
|
044235042 |
|
Email:
|
gratikpooh@hotmail.com |
|
Affiliation:
|
- |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: severe preeclampsia pregnant women
Exclusion criteria: renal disease
Cr>1.2
Age minimum:
15 Years
Age maximum:
40 Years
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
magnesium supratherapeutic level
magnesium, preeclampsia, excessive weight
|
|
magnesium, preeclampsia, excessive weight
|
|
Intervention(s)
|
|
comparison of different dosages of magnesium sulfate ,comparison of different dosages of magnesium sulfate
|
|
Experimental Drug,Experimental Drug
|
|
magnesium sulfat 2 g/h,magnesium sulfate 1 g/h
|
|
Primary Outcome(s)
|
|
magnesium level (therapeutic/sub therapeutic/supratherapeutic) magnesium therapeutic level magnesium level
|
|
Secondary Outcome(s)
|
|
Complications every periods of follow-up ocular examination
|
|
Source(s) of Monetary Support
|
|
Maharat Nakhon Ratchasima Hospital
|
|
Ethics review
|
Status: Submitted, approved
Approval date:
Contact:
Maharat Nakhon Ratchasima hospital institutional review board
044235226 Ext.
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
31/07/2015 |
|
URL:
|
|
|
|